EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
David J. Chambers
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujii, M.
Right arrow Articles by Chambers, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujii, M.
Right arrow Articles by Chambers, D. J.
Related Collections
Right arrow Cardiac - pharmacology
Right arrow Cardiac - physiology
Right arrow Myocardial protection

Eur J Cardiothorac Surg 2005;28:821-831
© 2005 Elsevier Science NL

Myocardial protection with intermittent cross-clamp fibrillation: does preconditioning play a role?

Masahiro Fujii, David J. Chambers *

Cardiac Surgical Research/Cardiothoracic Surgery, The Rayne Institute, Guy's and St Thomas’ NHS Foundation Trust, St Thomas’ Hospital, London SE1 7EH, UK

Received 4 April 2005; received in revised form 14 June 2005; accepted 27 June 2005.

* Corresponding author. Tel.: +44 20 7261 0157; fax: +44 20 7928 0658. (Email: david.chambers{at}kcl.ac.uk).

Objective: Previously, we showed intermittent cross-clamp fibrillation afforded equivalent protection to cardioplegia. This study examined whether protection induced by intermittent cross-clamp fibrillation involves an ischemic preconditioning mechanism. Methods: Isolated Langendorff-perfused rat hearts were subjected to three different studies to determine: Study 1, whether a single intermittent cross-clamp fibrillation episode (10 min) and reperfusion (10 min) before prolonged ischemia acts as a preconditioning trigger for protection; Study 2, whether cardioprotection induced by intermittent cross-clamp fibrillation alone (no prolonged ischemia) involves a preconditioning mechanism; Study 3, whether intermittent cross-clamp fibrillation cardioprotection can be prevented by targeting putative components of the preconditioning mechanism (protein kinase C or the mitochondrial ATP-sensitive potassium (KATP) channel). Hearts were reperfused (60 min) and recovery of function (left ventricular developed pressure measured using an intraventricular balloon) and myocardial injury (creatine kinase leakage) were measured. Results: In Study 1, recovery of function in the single intermittent cross-clamp fibrillation hearts was 61 ± 3% (mean ± SEM) (p < 0.05) compared to 41 ± 2% in control group; glibenclamide (a non-specific ATP-sensitive potassium (KATP)-channel blocker) prevented this preconditioning protection (37 ± 4%). In Study 2, recovery of function in intermittent cross-clamp fibrillation hearts (62 ± 3%) was significantly (p < 0.05) higher than intermittent cross-clamp fibrillation hearts treated with glibenclamide (33 ± 2%) and ischemia hearts (30 ± 5%). In Study 3, protection by intermittent cross-clamp fibrillation (60 ± 3%; p < 0.05) was attenuated by protein kinase C inhibition (chelerythrine, 34 ± 3%) and mitochondrial KATP-channel blockade (5-hydroxydecanoate, 27 ± 4%) to levels not significantly different from that of ischemia hearts (25 ± 4%). Conclusions: The cardioprotective efficacy of intermittent cross-clamp fibrillation was attenuated by protein kinase C inhibition or KATP-channel blockade. Involvement of these putative preconditioning cascade components in association with cardioprotection induced by intermittent cross-clamp fibrillation, suggests a role for the ischemic preconditioning mechanism.

Key Words: Research • Ischemia • Preconditioning • Left ventricular function • Heart preservation




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
P. K. Mishra
Fibrillatory arrest technique: is it worth tasting the old wine in new bottle?
Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 860 - 860.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
D. J. Chambers and M. Fujii
Reply to Mishra
Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 861 - 861.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Vaage
Editorial comment: Old skills in a new context--But do we want to use it?
Eur. J. Cardiothorac. Surg., December 1, 2005; 28(6): 831 - 832.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.